Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
309.41
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
41
42
Next >
Analyzing Amgen's Short Interest
May 02, 2022
Amgen's (NASDAQ:AMGN) short percent of float has fallen 7.95% since its last report. The company recently reported that it has 22.52 million shares sold short, which is 4.05% of...
Via
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...
Via
Benzinga
Here's How Much $100 Invested In Amgen 10 Years Ago Would Be Worth Today
April 29, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.04% on an annualized basis producing an average annual return of 12.67%. Currently, Amgen has a market capitalization of...
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
April 29, 2022
From
The Schall Law Firm
Via
Business Wire
Why Amgen Shares Are Trading Lower
April 28, 2022
Amgen, Inc. (NASDAQ: AMGN) shares are trading lower by 6.21% at $233.33 after the company reported first-quarter earnings results.
Via
Benzinga
Major Indexes Log Best Day Since Early March
April 28, 2022
The major indexes enjoyed a strong rebound on Thursday, with the Dow settling with a more than 614-point gain, nabbing its biggest daily jump since March 9.
Via
Talk Markets
Markets Surge Despite Drop In US GDP
April 28, 2022
U.S. indices traded higher Thursday despite a drop in U.S. GDP. Strength in stocks is possibly due to better-than-expected quarterly earnings from multiple companies as well as a...
Via
Benzinga
Check Out What Whales Are Doing With AMGN
April 28, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 18 strange trades.
Via
Benzinga
How is it going with the Big Biopharma Earnings Week?
April 28, 2022
Abbott and JNJ kicked off healthcare earnings last week and the results were just OK.
Via
Talk Markets
Piper Sandler Maintains Overweight Rating for Amgen: Here's What You Need To Know
April 28, 2022
Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00. Shares of Amgen are trading down 5.5% over the last 24 hours, at...
Via
Benzinga
Where Amgen Stands With Analysts
April 28, 2022
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings:
Via
Benzinga
Biotech Behemoth Amgen Tops First-Quarter Views, But 2022 Guidance Lags
April 27, 2022
Amgen stock fell late Wednesday on a surprise in its 2022 outlook despite a strong first-quarter showing.
Via
Investor's Business Daily
Molecular Partners Regains Rights To Early-Stage Cancer Asset From Amgen
April 27, 2022
Via
Benzinga
BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy
April 28, 2022
Via
Benzinga
Amgen's Return On Capital Employed Insights
April 28, 2022
Pulled from Benzinga Pro data, Amgen (NASDAQ:AMGN) posted Q1 earnings of $1.48 billion, an increase from Q4 of 22.27%. Sales dropped to $6.24 billion, a 8.88% decrease between quarters.
Via
Benzinga
Futures Rebound As Facebook Soars; Dollar Steamrolls Higher As Yen Crashes
April 28, 2022
U.S. index futures, European bourses, and Asian markets all rose as
Via
Talk Markets
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Amgen's Stelara-Based Biosimilar Shows Comparable Efficacy, Safety Profile For Psoriasis
April 19, 2022
Via
Benzinga
Amgen's Q1 Better Than Expected Sales, Profit Overshadowed By Tax Disclosure
April 28, 2022
Amgen Inc (NASDAQ: AMGN) has recently received a notice of deficiency from the Internal Revenue Service centered on 2013 to 2015.
Via
Benzinga
Recap: Amgen Q1 Earnings
April 27, 2022
Amgen (NASDAQ:AMGN) reported its Q1 earnings results on Wednesday, April 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by...
Via
Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Earnings Preview: Amgen
April 26, 2022
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Amgen will report an...
Via
Benzinga
What Stocks to Buy That Should Do Well in a Recession — Our 7 Top Picks
April 26, 2022
Americans will still use brand names, buy groceries and clothes, get healthcare services and pay their utilities during a recession. That's good news for these 7 recession-resistant stocks to buy.
Via
InvestorPlace
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
Via
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Drug development is a cumbersome process and M&A is a win-win proposition for both the acquirer and the target company.
Via
InvestorPlace
If You Invested $100 In Amgen 15 Years Ago, Here's How Much You Would Have Today
April 20, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 2.31% on an annualized basis producing an average annual return of 9.87%. Currently, Amgen has a market capitalization of...
Via
Benzinga
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider
April 19, 2022
These are the best long-term stocks to invest in now. AMGN, CRWD, and WBA can make great investments in Q2.
Via
InvestorPlace
Growth Is Struggling – Sunday, April 17
April 17, 2022
Growth stocks are struggling in 2022. This fact was apparent last week when I wrote about Buffett is Buying. However, this fact is not surprising.
Via
Talk Markets
Analyzing Amgen Inc's Short Interest
April 14, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 8.14% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 4.4%...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.